Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group
published in: European Journal of Cancer
date of publication: 2011-05-10
main subject: patient, oxaliplatin, pancreatic cancer, fluorouracil
Cites articles 1
Date
Title
Article - wd:Q34629100